SCREENING FOR EXTRAGENITAL CT/GC AMONG HIV-INFECTED MSM: A COMPARISON OF 4 NAATS
CDC recommends annual screening for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) using NAAT at sites of exposure in adults with HIV. NAAT is highly sensitive but testing is not FDA-approved at rectal and pharyngeal sites and several testing platforms have become available. Although HIV-infected MSM have high incidence rates of rectal and pharyngeal CT/GC,…